Vadadustat 900mg
HSC-MS-22-0260
Phase 3 small_molecule active
Quick answer
Vadadustat 900mg for Nonintubated Acute Respiratory Distress Syndrome (ARDS) is a Phase 3 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Nonintubated Acute Respiratory Distress Syndrome (ARDS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active